Impact of placental Plasmodium falciparum malaria infection on the Cameroonian maternal and neonate’s plasma levels of some cytokines known to regulate T cells differentiation and function by Jean Claude Djontu et al.
Djontu et al. Malar J  (2016) 15:561 
DOI 10.1186/s12936-016-1611-0
RESEARCH
Impact of placental Plasmodium 
falciparum malaria infection on the 
Cameroonian maternal and neonate’s plasma 
levels of some cytokines known to regulate T 
cells differentiation and function
Jean Claude Djontu1,2, Stalone Siewe Siewe1,2, Yolande Delphine Mpeke Edene1,2, Benderli Christine Nana1,2, 
Edwige Vanessa Chomga Foko1,2, Jude Daiga Bigoga2,3, Rose F. G. Leke2 and Rosette Megnekou1,2*
Abstract 
Background: The impact of placental malaria (PM) infection on the expression profile of some cytokines known to 
regulate T cell differentiation and function and their influence on birth weight remain unclear. Moreover, there are no 
reports showing the relationship between PM and IL-27 or IL-28A. This study therefore sought to investigate whether 
placental P. falciparum infection alters the expression profile of the cytokines IL-28A, IL-27, IL-17E and IL-6 in mothers 
and their new born.
Methods: In a cross-sectional study conducted between 2013 and 2015 in Yaoundé, Cameroon, peripheral, placental 
and cord blood samples were collected from 108 women at delivery. Parasitaemia was determined microscopically 
and haemoglobin levels determined using a Coulter counter. Plasma levels of cytokines (IL-28A, IL-27, IL-17E and IL-6) 
were measured by Luminex magnetic screening assay.
Results: Malaria parasite density in placenta impression smear associated negatively with maternal haemoglobin 
level (P < 0.0001) and baby birth weight (P = 0.016). While IL-17E, IL-27 and IL-28A levels were significantly higher in 
placental and cord plasma than in peripheral (P < 0.0001, < 0.001 and P = 0.026, respectively), an opposite relation-
ship was observed with IL-6 (P = 0.0018). Multivariate analysis confirmed results of univariate analysis where the 
presence of malaria parasites or pigments in placenta tissue impression smears correlated with decrease levels of 
maternal IL-17E, IL-27 and IL-28A and neonate levels of IL-28A and IL-17E (0.0001 ≤ P ≤ 0.02). Placental and peripheral 
parasitaemias also correlated positively with peripheral plasma levels of IL-6 (rs = 0.18, P = 0.05 and rs = 0.17, P = 0.07, 
respectively). In addition, high maternal haemoglobin level associated with increasing levels of IL-17E, IL-27 and IL-28A 
in peripheral plasma (0.002 ≤ P ≤ 0.018) and high placental and cord plasma levels of these cytokines associated with 
increasing birth weight (0.0001 ≤ P ≤ 0.0027).
Conclusions: Placental malaria downregulates maternal plasma levels of IL-17E, IL-27 and IL-28A and neonates’ 
plasma levels of IL-17E and IL-28A cytokines, which could help for parasite clearance and increase child birth weight. 
The study is expected to provide leads that should help identify potential biomarkers for improved birth weight and 
therapeutic interventions.
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Background
During pregnancy, Plasmodium-infected erythrocytes 
(IEs) accumulate in the placenta [1, 2], inducing attrac-
tion of some leucocytes in the organ, pathological 
changes that alter the materno-fetal exchange system and 
result into intra-uterine growth retardation and low birth 
weight [3]. It also alters cytokine expression profile [4–7]. 
Although cytokines play a crucial role in pathogen clear-
ance, they could also elicit adverse outcomes in several 
infectious diseases if their secretion is not well regulated. 
Thus, accumulation of IEs in the placenta can alter the 
anti-inflammatory/pro-inflammatory cytokines balance, 
which might play a dominant role in the pathophysiol-
ogy of placental malaria (PM) [5, 8]. Indeed, a successful 
pregnancy is characterized by the predominance of anti-
inflammatory cytokines at the feto-maternal interface 
that downregulates inflammatory response, which could 
be detrimental to the fetus [9]. Also, the accumulation of 
Plasmodium falciparum-infected erythrocytes and leu-
cocytes in the placenta is associated with alteration in 
cytokine expression and some oxidative stress biomark-
ers profiles [10, 11]. The infiltrated leukocytes are the 
principal sources of inflammatory cytokines production 
[8, 12]. Among the cytokines produced, IL-27 and IL-6 
can elicit both pro-inflammatory and anti-inflammatory 
effects. In fact, IL-27 has been described to induce T 
helper 1 (Th1) cell associated transcription factor T-bet, 
which enhances Th1 differentiation [13, 14], while other 
studies showed that it inhibits the development of IL-
17-producing helper T (Th-17) cells [15] and decreases 
Th2 response [16]. IL-6 cytokine inhibits transform-
ing growth factor-β (TGF-β)-induced IL-10-producing 
regulatory T cell (Treg) differentiation [17] but together 
with (TGF)-β, it preferentially promotes the differentia-
tion of IL-17-producing T helper cells (Th17) [18]. IL-
17E (IL-25) can be produced by mucosal epithelial cells 
as well as many immune cell types, including mast cells, 
macrophages, eosinophils, Th2 cells, and NKT cells [19, 
20]. It is involved in Th2 cell-promoting cytokine [21] 
and suppresses Th17 cell responses. As regards IL-28A, 
previous studies presented this cytokine as a newly desig-
nated type III interferon (IFN)-λ, having antiviral effects 
[22, 23] and produced principally by antigen-presenting 
cells (APCs) [24]. This cytokine can improve the Th17-
induced inflammation, provide Th1 polarization and 
antagonize Th2 responses [25]. Therefore, IL-6, IL-27, IL-
17E, and IL-28A are critical cytokines possibly involved 
in the regulation of human immunological diseases 
induced by Th1, Th2, Treg, and Th-17 cells response 
imbalance [26].
As observed previously during PM, CXCL-10 
chemokine might attract monocytes and lymphocytes 
into the placenta where they produce cytokines (IL-10 
and IL-17A) whose levels affect parasite clearance and 
modulate the disease [10]. In addition, high plasma levels 
of some inflammatory cytokines, such as Th1 cells-IFN-γ 
and Th-17 cells-IL-17A, have been shown to correlate 
with the absence of pregnancy-associated malaria in 
Cameroonian women [27], while over-expression of 
IL-10 may be associated with the persistence of malaria 
parasites in the placenta leading to low birth weight 
babies [8, 10]. In addition, some studies have shown that 
IL-27-producing CD4+ T cells may play a role in the reg-
ulation of protective immune response against malaria 
[28]. Although the differentiation and function of IFN-γ, 
IL-10 and IL-17A-producing T cells are critically influ-
enced by IL-6, IL-27, IL-17E, or IL-28A cytokines, the 
impact of placental P. falciparum infection on the expres-
sion profile of these regulatory cytokines in women at 
delivery and its influence on birth weight is unknown. 
Therefore, this study was carried out to better under-
stand the alteration in cytokine homeostasis in women 
with PM and its consequences on birth weight. The study 
is expected to provide leads that should help identify 




Between May 2013 and January 2015, a cross-sectional 
survey was carried out at the Marie Reine Health Centre 
in Etoudi, Yaoundé, Cameroon, to evaluate the impact of 
placental P. falciparum infection on the expression profile 
of some regulatory cytokines in women at delivery and 
its influence on birth weight. The study site and popula-
tion as well as the sample collection have been described 
elsewhere [10]. Peripheral, placental and cord blood sam-
ples were aseptically collected in EDTA tubes from 108 
women aged 16–39 years immediately following delivery. 
A portion of each sample was used to prepare smears for 
malaria microscopy. The remainder was centrifuged and 
the plasma stored at −80 °C for cytokine measurements. 
Placental tissues were also collected and used to prepare 
impression smears and for histology. The study partici-
pant characteristics are summarized in Table 1.
Diagnosis of placental malaria and determination 
of haemoglobin levels
For malaria microscopy, maternal peripheral, placen-
tal and cord blood were used to prepare thick and thin 
blood smears while placenta tissue was used to prepare 
impression smears. Slides were stained using Giemsa and 
examined for the presence of malaria parasites. Plasmo-
dium falciparum infection was further confirmed using 
the rapid diagnostic test, malaria Carestart™ HRP2 (Pf ) 
(Access Bio Inc, NJ, USA). Placental tissue sections 
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were fixed in buffered formalin, embedded, stained with 
haematoxylin-eosin, and examined for the presence of 
parasites and malaria pigments. A woman was consid-
ered placental P. falciparum positive if infected eryth-
rocytes were detected in impression smears of placenta 
tissue, placental blood smear or in histological sections. 
The presence of malaria pigment in placental tissue was 
declared when detecting pigment within monocytes from 
placental impression smear or/and in intervillous spaces 
of placental histological sections. Haemoglobin (Hb) lev-
els in maternal blood and neonate cord blood were deter-
mined using a Coulter counter (URIT-3300, Europe). A 
woman was considered anaemic if Hb < 11 g/dL.
Measurement of cytokines
Plasma levels of IL-6, IL-17E, IL-27, and IL-28A were 
measured by magnetic luminex screening assay, using 
Human Premixed Multi-Analyte Kit (R&D Systems, Inc. 
Minneapolis, MN, USA). Human, magnetic, premixed, 
microparticle cocktail of antibodies specific to IL-6, 
IL-17E, IL-27, and IL-28A was used to simultaneously 
screen maternal peripheral, placental and neonate cord 
plasma. The assay was carried out according to manu-
facturer’s instructions. Briefly, plates were incubated on 
the horizontal shaker with 50 µL/well of different diluted 
samples and concentration of standard cytokines pro-
vided alongside with 50  µL of human, magnetic, pre-
mixed, microparticle cocktail with antibodies specific 
for each cytokine. After washing using magnetic plate 
separator (Luminex, Austin, TX, USA, Cat# CN-0269-
01), plates were incubated with 50  µL/well of human 
premixed biotin-antibodies cocktail specific for each 
cytokine. Antibody-cytokine complexes were revealed 
using Streptavidin-PE. Plates were read using a Luminex 
MAGPix Analyzer (XMAP Technology, SN, USA) and 
results were expressed as median fluorescence intensity 
(MFI). A standard curve was generated for each cytokine 
to convert MFI into corresponding cytokine relative con-
centration. The sensitivity of the assay for each cytokine 
was: 0.2 pg/ml (IL-6), 4.5 pg/ml (IL-17E), 3.6 pg/ml (IL-
27), and 8.4  pg/ml (IL-28A), which was the minimum 
detectable concentration of each cytokine.
Statistical analyses
The GraphPad Prism 5.03 software was used for statisti-
cal analyses. Results were reported as medians with 95% 
confidence intervals. Mann–Whitney rank sum test was 
used to evaluate inter-group differences in the levels of 
cytokines. Spearman rank order coefficient (rs) was used 
to evaluate parameter association. Regression analy-
sis was used to identify significant association between 
cytokines tested and other parameters. Proportions were 




The baseline characteristics of the study participants 
are summarized in Table  1. Twenty-four (22.5%) of the 
women were positive for placental P. falciparum infec-
tion amongst whom 15 (62.5%) were positive for the 
placental and peripheral blood as well as the impression 
smears of placental tissue; four (16.66%) were positive 
for the peripheral blood and impression smears of pla-
cental tissue, while five (20.8%) were positive only for 
the impression smears of placental tissue. With regards 
to malaria rapid diagnostic test (RDT), 28 out of the 
108 women (26%) were positive, of which 23 (82%) were 
Table 1 Characteristics of the study population
Mann–Whitney Rank Sum Test was used to compare different variables between infected and non-infected women
Values in the parentheses represent either percentage or range
Significant p values are in italics (p ≤ 0.05)
PM placental malaria negative women; PM + placental malaria positive women
Parameters All women (n = 108) PM + women (n = 24) PM-women (n = 84) P value
Age, median (range), years 25 (16–37) 25 (16–37) 26 (17–37) 0.2
Primipara 39 (36%) 9 (23%) 30 (77%)
Secondipara 26 (24%) 8 (30%) 18 (70%)
Multipara 43 (40%) 7 (16%) 36 (84%)
Hb levels (g/dL) 12.6 (7.5–15.7) 10.7 (7.5–12) 12.9 (10–15.7) <0.0001
Baby birth weight (g) 3350 (1900–4850) 3200 (2100–3700) 3400 (1900–4850) 0.016
Malaria by RDT 28 (26%) 23 (82%) 5 (18%)
Malaria by peripheral blood smears 19 (18%) 19 (100%) 0 (0%)
Malaria by placental blood smears 15 (14%) 15 (100%) 0 (0%)
Placental malaria by histology 16 (15%) 16 (100%) 0 (0%)
Malaria pigments 14 (13%) 13 (93%) 1 (7%)
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women with infected placenta. These observations con-
firm that multiparous women (16%) were less likely to 
have placental malaria compared to the secondiparous 
(30%) (P = 0.02) and primiparous (23%) (P = 0.2). There 
was no significant difference in median age between P. 
falciparum-infected and non-infected women (P = 0.2). 
Hb level was lower in malaria-infected women com-
pared to non-infected (P  <  0.0001). Birth weight from 
women with infected placenta was lower compared to 
the non-infected (P = 0.016). Histological studies showed 
that malaria pigment in placental tissue was more fre-
quent among infected women compared to non-infected 
women (P < 0.0001). In fact, malaria pigment in placental 
tissue was found in 13 (54.1%) of placental malaria-posi-
tive women, while only one woman (1.1%) was found to 
have malaria pigment among the placental malaria nega-
tive women.
Parasitaemia was observed to increase significantly 
with decreasing peripheral and cord blood Hb levels as 
well as baby birth weight [(r s = −0.55, −0.23 and −0.25), 
P  <  0.0001, 0.015 and 0.011, respectively)]. A similar 
but non-significant trend was observed with parity and 
mother’s age [(rs = −0.10 and −0.14), P = 0.32 and 0.16, 
respectively)]. These results confirm that babies born 
from infected mothers are more likely to have low birth 
weight compared to those non-infected.
Plasma level of IL-17E, IL-27 and IL-28A cytokines are 
elevated in the placental and cord blood while IL-6 is 
higher in peripheral blood
In order to determine whether the profile of the 
cytokines varied with the collection sites, levels of IL-6, 
IL-17E, IL-27, and IL-28A in the peripheral plasma were 
compared with those in placental and cord plasma. The 
plasma levels of IL-17E, IL-27 and IL-28A were sig-
nificantly higher in placental than in peripheral plasma 
(P  <  0.0001,  <  0.001 and P =  0.026, respectively), while 
levels of IL-6 were instead higher in the peripheral 
plasma (P = 0.0018) (Fig. 1; Table 2). Although there was 
no significant difference in the levels of IL-17E and IL-
28A between placental and cord plasma, IL-27 and IL-6 
levels were significantly higher in placental plasma than 
in cord plasma (P = 0.0010 and P < 0.001, respectively). 
These results suggest that IL-17E, IL-27 and IL-28A 
are synthesized in the placenta with IL-28A and IL-17E 
crossing the placenta barrier, leading to their observed 
high levels in cord blood.
Plasmodium falciparum parasiteamia correlated negatively 
with maternal levels of IL-17E, IL-27, and IL-28A, 
but positively with IL-6
To investigate whether placental malaria influences the 
expression profile of IL-28A, IL-27, IL-17E and IL-6 in 
maternal and neonate blood, the levels of these cytokines 
were compared between women with infected placenta 
and those without. Women with infected placenta had 
lower levels of IL-28A, IL-27 and IL-17E in peripheral 
plasma compared to their non-infected counterparts 
(P =  0.03, 0.005 and 0.03, respectively (Fig.  2). In addi-
tion, the levels of these cytokines in peripheral plasma 
correlated negatively with the parasitaemia from pla-
centa tissue impression smear [(rs = −0.20; P =  0.02; r 
s = −0.28; P =  0.002; rs = −0.21; P =  0.028)], periph-
eral blood smear [(rs  =  −0.20; P  =  0.03; rs  =  −0.30; 
P = 0.001; rs = −0.21; P = 0.029)], respectively, and from 
the placental blood smear only for IL-27 (rs  =  −0.23, 
P  =  0.014) (Table  3). Although higher in non-infected 
women, no significant difference was observed in the 
cord plasma levels of IL-28A and IL-17E between 
women with infected and non-infected placenta (Fig. 2). 
While no difference was observed between the infected 
and non-infected women for IL-27 and IL-17E placen-
tal plasma levels, that of IL-28A was higher in the non-
infected women although not significant. In addition, 
negative correlations were observed between parasitae-
mias and cord plasma levels of IL-28 A, IL-17E or pla-
cental level of IL-28A (Table  3). With regards to IL-6, 
its peripheral levels correlated positively with placental 
parasitaemia (rs =  0.18, P =  0.05) and peripheral para-
sitaemia (rs =  0.17, P =  0.07) (Table 3). Together, these 
suggest that placental P. falciparum infection may be 
associated with decrease in peripheral plasma levels of 
IL-28A, IL-27 and IL-17E and increase IL-6 level. 
Chronic placental malaria infection is associated 
with decrease plasma levels of maternal IL-17E, IL-27, 
IL-28A and neonate IL-17E and IL-28A
According to Rogerson et al. [29], the presence of malaria 
parasites and pigment in placental tissue of women indi-
cates a chronic infection, while an acute infection is 
defined as the presence of malaria parasite in placental 
tissue without pigment. The presence of malaria pigment 
only indicates past infection. Therefore, the cytokine lev-
els in women with chronic infection (n = 13) were com-
pared to those of women with acute infection (n =  11) 
and women with no malaria parasite and pigment in pla-
cental tissue (n = 83) (Fig. 3). Results showed lower levels 
of IL-28A in the peripheral, placental and cord plasma of 
women with chronic infection compared to those with 
acute infection (P = 0.008, 0.0085 and 0.06, respectively) 
and those with neither parasite nor pigment in placental 
tissue (P = 0.0001, 0.0088 and 0.0078, respectively). Lev-
els of IL-17E and IL-27 in peripheral plasma were also 
lower in women with chronic infection than in those 
with acute infection (P =  0.058 and 0.021, respectively) 
and with neither parasite nor pigment in placental tissue 
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(P = 0.0017 and 0.0004, respectively). The level of IL-17E 
in cord blood was slightly lower in women with chronic 
infection compared to those with no parasite and pig-
ment in placental tissue (P = 0.057). Regarding IL-6, its 
level in peripheral, placental and cord plasma was slightly 
higher in women with chronic infection than in those 
with infection or with neither malaria parasite nor pig-
ment in the placenta. The difference was also not signifi-
cant (P > 0.2).
Maternal haemoglobin level correlated positively 
with levels of IL-17E, IL-27 and IL-28A in peripheral blood 
while high levels of these cytokines in placental and cord 
blood increased with increasing baby birth weight
In this study, multipara women were less likely to be 
infected by malaria parasites compared to the secondi-
para and primipara. Also, PM correlated with decrease 
in maternal Hb level (P  <  0.0001) and birth weight 
(P  =  0.016) (Table  1). Therefore, the relationships 
between levels of assayed cytokines and parameters such 
as maternal Hb level, baby birth weight, parity, and moth-
er’s age were investigated. Maternal Hb levels correlated 
positively with the levels of IL-28A, IL-27 and IL-17E in 









































































Fig. 1 Changes in plasma levels of cytokines between peripheral, placental and cord blood at delivery. Plasma levels of IL-28A, IL-27, IL-17E, and 
IL-6 cytokines in peripheral blood were compared with that in placental and cord blood from Cameroonian women using Mann–Whitney Ran 
Sum test. Box represents median with 25 and 75 percentiles. Per peripheral blood; Pla placental blood; Cord blood (N = 108). *P < 0.05; **P ≤ 0.001; 
***P ≤ 0.0001
Table 2 Cytokine levels between  peripheral, placental 
and cord plasma
Values outside the bracket correspond to the median while values in bracket 
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(Table  4). Placental and cord plasma levels of IL-28A 
and IL-27 were significantly elevated in women having 
babies with birth weight higher than mean birth weight 
of -3SD (2800 g) compared to women having babies with 
birth weight equal to or lower than mean birth weight of 






























































































Fig. 2 Plasma levels of IL-28A, IL-27, IL-17E and IL-6 cytokines in PM-negative and PM-positive women. Plasma levels of IL-28A, IL-27, IL-17E, and IL-6 
cytokines were compared between PM-negative (N = 84) and PM-positive (N = 24) women using Mann–Whitney Rank Sum test. Box represents 
median with 25 and 75 percentiles. * P < 0.05; **P ≤ 0.001. PM Placental malaria
Table 3 Correlations between cytokine levels and different parasitaemias
The Spearman’s rank order correlation test was used
Significant p values are in italics (p ≤ 0.05)
rs Coefficient of correlation; IRBCs infected red blood cells; Per Peripheral plasma; Pla Placental plasma; Cord Cord plasma; IL Interleukin
Cytokines % IRBCs of impression smear (from 
placenta tissue) (n = 108)
Placental blood parasitaemia Peripheral blood parasi-
taemia
rs P value rs P value rs P value
IL-28 A per −0.20 0.02 −0.10 0.28 −0.20 0.03
IL-28 A pla −0.15 0.12 −0.12 0.20 −0.12 0.21
IL-28 A cord −0.15 0.10 −0.14 0.13 −0.11 0.24
IL-27 per −0.28 0.002 −0.23 0.015 −0.30 0.001
IL-27 pla −0.05 0.54 −0.003 0.97 −0.03 0.68
IL-27 cord −0.01 0.83 −0.005 0.95 −0.002 0.98
IL-17 E per −0.21 0.028 −0.12 0.19 −0.20 0.029
IL-17 E pla −0.002 0.98 −0.05 0.54 −0.02 0.77
IL-17 E cord −0.14 0.13 −0.14 0.13 −0.10 0.28
IL-6 per 0.09 0.35 0.18 0.05 0.17 0.07
IL-6 pla −0.01 0.84 0.04 0.61 0.01 0.85
IL-6 cord −0.002 0.98 0.07 0.44 0.04 0.64
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plasma levels of IL-28A and IL-27) and (P = 0.0027 and 
0.0053, respectively for cord plasma levels of IL-28A and 
IL-27)] (Fig. 4). Although the placental plasma level of IL-
17E was not significantly different in these two groups of 
(P = 0.36), its cord plasma level was significantly higher 
in the group of women having babies with birth weight 
higher than mean birth weight of-3SD (P = 0.0034). Fur-
thermore, baby birth weight was observed to correlate 
positively with levels of IL-28A, IL-27 and IL-17E, in pla-
cental plasma (rs = 0.29, 0.29 and 0.16; P = 0.002, 0.002 
and 0.09), respectively) and cord plasma (rs = 0.40, 0.35 
and 0.38; P ≤ 0.0002, for all), respectively (Table 4). Lev-
els of IL-28A and IL-27 in placental plasma (rs  =  0.18; 
P = 0.05) and (rs = 0.23; P = 0.01) as well as cord plasma 
levels of IL-17E (rs  =  0.19; P  =  0.04) correlated posi-
tively and significantly with parity. Only placental lev-
els of IL-27 associated significantly with mother’s age 
(rs = 0.20, P = 0.03) (Table 4). None of these parameters 
associated significantly with levels of IL-6. Together, 
these results suggest the invaluable roles of IL-28A, IL-27 
and IL-17E during pregnancy for normal fetal growth. 
Regression analysis models on cytokine production
Based on the observed co-variation of parity and mother’s 
age influencing cytokine levels in the univariate analyses 
described above, and the potential effects of malaria infec-
tion, Hb levels and baby birth weight, the impact of these 
variables were jointly tested using regression analysis. 
Results confirmed the univariate analysis. In fact, an asso-
ciation between the decrease in IL-28A, IL-27 levels in 
peripheral and placental plasma, IL-28A and IL-17E levels 
in cord plasma and the presence of malaria parasites or pig-
ments in placenta tissue was observed (0.0001 ≤ P ≤ 0.02). 
The model also showed an association between high levels 
of Hb and levels of IL-28A, IL-17E and IL-27 in peripheral 
blood (0.002 ≤ P ≤ 0.018) on one hand, and between high 
levels of these cytokines in placental plasma, cord plasma 
and increasing birth weight (0.0001 ≤ P ≤  0.0027) on the 
other. With regards to IL-6, regression analysis showed that 
its peripheral levels increased with decreasing mother’s age 
(P = 0.05), while high levels of IL-6 in placental plasma asso-
ciated with an increased parasitaemia between the impres-





































































































Fig. 3 Plasma levels of cytokines in delivering women with chronic infection, acute infection and with no malaria parasite and pigment in the pla-
centa tissue. Plasma levels of IL-28A, IL-27, IL-17E, and IL-6 cytokines were compared between women with chronic infection (N = 13), acute infec-
tion (N = 11) and women without malaria parasites and pigment in placenta tissue (N = 83), using Mann–Whitney Rank Sum test. Box represents 
median with 25 and 75 percentile *P < 0.05; **P ≤ 0.001; ***P ≤ 0.0001
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Table 4 Correlation between cytokine levels and hemoglobin levels, parity, mother’s age and baby weight
Significant p values are in italics (p ≤ 0.05)
The Sperman’s rank Order correlation test was used. Per Peripheral plasma; Pla Placental plasma; Cord Cord plasma; Hb Haemoglobin level; IL Interleukin; rs Coefficient 
of correlation
Cytokines Hb per Birth weight Parity Mother age
rs P rs P rs P rs P
IL-28 per 0.24 0.012 −0.01 0.88 0.10 0.28 0.14 0.12
IL-28 pla 0.09 0.34 0.28 0.002 0.18 0.05 0.12 0.18
IL-28 cord 0.15 0.10 0.39 <0.0001 0.07 0.45 0.05 0.56
IL-27 per 0.28 0.002 0.11 0.23 −0.05 0.60 0.02 0.82
IL-27 pla 0.009 0.92 0.28 0.002 0.23 0.01 0.20 0.03
IL-27 cord −0.06 0.48 0.35 0.0002 0.11 0.22 0.03 0.72
IL-17E per 0.25 0.008 0.030 0.75 0.11 0.24 0.12 0.18
IL-17E pla 0.003 0.97 0.16 0.09 0.14 0.12 0.08 0.38
IL-17E cord 0.08 0.38 <0.0001 0.19 0.04 0.11 0.26
IL-6 per −0.05 0.59 0.02 0.78 −0.14 0.14 −0.04 0.64
IL-6 pla 0.03 0.74 −0.02 0.83 0.08 0.40 0.09 0.33






bw ≥ mean bw-3sd
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Fig. 4 Plasma levels of cytokines in women at delivery in relation with birth weight. Plasma levels of IL-28A, IL-27, IL-17E, and IL-6 cytokines 
were compared between women having baby with birth weight > mean birth -3Sd (2800 g) (n = 89) and women having baby with birth 
weight ≤ mean birth -3Sd (n = 19), using Mann–Whitney Rank Sum test. bw birth weight. Box represents median with 25 and 75 percentile 
*P < 0.05; **P ≤ 0.005
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Discussion
Disturbance of cytokines equilibrium has been linked to 
many pathological disorders, including poor pregnancy 
outcomes. Although the accumulation of P. falciparum-
infected erythrocytes in placenta has been shown to 
cause the alteration of T cells cytokines expression pro-
file in feto-maternal interface [8, 10], the impact of this 
infection on the plasma levels of some maternal and 
neonate cytokines known to regulate T cells differentia-
tion and function and how this could affect birth weight 
remain undefined. This study aimed to investigate the 
relationship between placental P. falciparum infection 
and the plasma levels of IL-28, IL-27, IL-17E, and IL-6 
in Cameroonian maternal and neonate plasma in rela-
tion with pregnancy outcomes (birth weight and Hb 
levels). In general, levels of IL-28A, IL-27 and IL-17E 
cytokines were observed to be significantly higher in pla-
cental and cord plasma than in peripheral plasma. This 
was as opposed to IL-6 where its levels were higher in 
peripheral plasma, suggesting that the feto-maternal 
unit could be the primary source of IL-17E, IL-27 and 
IL-28A production. Indeed, the syncytiotrophoblast of 
the placental tissues has been shown to contribute to 
the production of a number of cytokines, which help in 
placental growth and fetal tolerance [30, 31]. In addition, 
cytokines environment in maternal placenta and in fetal 
cord blood has been shown to have significant effects on 
baby birth weight [32]. While a previous study demon-
strated an association between cord blood cytokine lev-
els of IFN-γ, IL-1β, TNF-α, IL-12p70, IL-10 cytokines, 
and reduced birth weight [33], this study, for the first 
time, shows that levels of IL-28A, IL-27 and IL-17E are 
elevated in cord plasma rather than in maternal periph-
eral plasma, and correlate positively with increasing baby 
birth weight. This positive association between birth 
weight and both the Th1-promoting (IL-27, IL-28A) and 
Th2-promoting cytokines (IL-17E) is consistent with the 
findings of Chêne and colleagues, who reported an asso-
ciation between low birth weight and decreasing level of 
both IFN-γ and IL-5 in intervellous plasma samples from 
Beninese women [34]. Findings from this study indicate 
that IL-28A, IL-27 and IL-17E cytokines might be impli-
cated in fetal growth and suggest that a better under-
standing of the fetal environment mediated by multiple 
cytokines may be important for optimizing fetal growth 
outcomes in many settings.
With regard to PM infection, plasma levels of periph-
eral IL-28A, IL-27 and IL-17E were significantly lower in 
malaria infected than in malaria non-infected women. 
All these cytokines correlated negatively and significantly 
with the parasite densities from impression smears and 
peripheral blood. Although not significant, negative 
correlations were also found between placenta blood 
parasitaemia and plasma levels of placental IL-28A, IL-27 
and IL-17E. Similarly, a negative correlation was found 
between different parasitaemias and cord IL-17E, IL-
28A. The presence of both malaria parasites and pigment 
in the placental tissue associated significantly with low 
levels of IL-28A in peripheral, placental and cord plasma, 
as well as the levels of IL-28A in the placental and cord 
plasma and for a lesser extend IL-17E in cord plasma. 
These results suggest that PM is associated with decrease 
maternal IL-28A, IL-27 and IL-17E and neonates’ IL-
28A and IL-17E. These results are in agreement with 
that of a previous study showing an association between 
pregnancy-associated malaria and reduced plasmacytoid 
dendritic cells [35], shown to be the main source of IL-
28A production [36]. Previous studies have established 
an association between high malaria parasitaemia and 
low levels of IFN-γ and IL-17A during pregnancy and at 
delivery [10, 27]. This is the first study showing the lower-
ing effect of placental P. falciparum infection on the IL-
28A, IL-27 and IL-17E production. This might be due to 
the protective effects of the cytokines against the infec-
tion. However, although the mechanism is unknown, the 
association of PM with low levels of cytokines in non-
infected cord blood might suggest that PM lowers the 
levels of these cytokines. Nevertheless, the role of IL-28A 
in the control of other diseases has been proven. In fact, 
IL-28A is considered a new approach for the treatment of 
asthma because its production by the plasmacytoid cells 
polarizes the immune response through activated Th1 
type and the production of the INF-γ [37]. This cytokine, 
as well as IL-27 and IL-17E, are known to be the main 
regulators of T cell differentiation and function [26, 38]. 
Alteration of their expression might be implicated in the 
decrease of these T cells cytokines (IFN-γ and IL-17A) 
observed previously. Akin to IL-28A, IL-27 and IL-17 
E cytokines, IL-6 also plays a crucial role in T cells dif-
ferentiation and immune response polarization. It has 
been shown to inhibit TGF-β-induced IL-10-producing 
regulatory T cell (Treg) differentiation [17], but together 
with transforming growth factor (TGF)-β, preferentially 
promotes the differentiation of IL-17-producing T helper 
cells (Th17) [18, 39]. Regression analysis showed that its 
peripheral levels increased with decreasing mother age 
while high levels of placental plasma IL-6 associated with 
increased parasitaemias from the impression smears 
and placenta blood. However, the univariate analysis 
showed positive correlations between peripheral IL-6 
levels and placental blood parasiteamia. A similar trend 
was observed with peripheral and impression smear 
parasitaemias, but was not significant. A positive associa-
tion between malaria infection and plasma levels of this 
cytokine in women during pregnancy in north-eastern 
Tanzania was reported [40]. Secretion of IL-6 has been 
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shown to increase progressively in pregnant women from 
labour until parturition. The non-significance observed 
in this study could be explained by the fact that the pro-
duction of this cytokine is influenced by an immunophys-
iological condition occurring during labour. There was 
no significant association between plasma levels of IL-6 
in placental and neonate blood, as well as placental P. fal-
ciparum infection.
PM is known to cause maternal anaemia and low birth 
weight. Thus, the positive association observed between 
the levels of IL-17E, IL-28A, IL-27, and maternal Hb or 
between baby birth weight and these cytokines in pla-
cental and cord blood, suggest that these cytokines could 
play protective roles in PM. Indeed, previous studies 
reported that placental accumulation of IEs might stim-
ulate Th1 cytokine release through macrophages [8, 41] 
to aid parasite clearance, possibly through complement 
activation [42], increased phagocytic activity and by the 
production of reactive oxygen species and nitric oxide 
(NO) metabolites [43]. Other studies demonstrated that 
IL-28A and IL-27 cytokines induce the Th1 polarizing 
cytokines (IFN-γ and IL-12) that protect against malaria 
in human and animal models [44, 45]. Akin to this, the 
positive correlation observed between parity and levels of 
IL-27 and IL-28A in placental plasma support the poten-
tial protective role of the three cytokines in PM, as this 
disease has been shown to be less prevalent and less com-
plicated in multiparous than in primiparous women.
Conclusions
PM is associated with the downregulation of plasma lev-
els of maternal IL-17E, IL-27, IL-28A, and neonates’ IL-
17E and IL-28A cytokines, which might contribute to 
parasite clearance and enhancement of baby birth weight. 
These data would contribute to a better understanding 
of the alteration in cytokine homeostasis in PM patients 
and their neonates, and provide leads that should help 
identify potential biomarkers for improved birth weight 
and therapeutic interventions.
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